15Apr 2023
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease

Novel and future lipid-modulating therapies for the prevention of cardiovascular disease

Reducing LDL cholesterol in plasma lowers the risk of cardiovascular disease. Other lipoproteins, such as triglyceride-rich lipoproteins, HDL, and lipoprotein(a), also contribute to atherosclerosis and ASCVD. Researchers have identified key proteins involved in lipoprotein metabolism, including PCSK9, angiopoietin-related protein 3, cholesteryl ester transfer protein, and apolipoprotein(a), as potential targets for therapeutic intervention. These targets can be approached using protein inhibition, mRNA level inhibition, or genome editing. These novel strategies complement and potentially replace current therapies, offering unprecedented opportunities to prevent ASCVD. New approaches, such as genome editing, could provide long-lasting reductions in causal exposures.

  • #cardiology

Like

Save

Share